An alternative explanation is that intrinsically heterogeneous tumor cells (11 clusters) respond differently to anti-PD-1 treatment, although a minimal difference in tumor cells was observed between responders and non-responders (Supplemental Figure S6). The gene discussed is PDCD1; the disease is neoplasm.